SCHEMBL5582695

SCHEMBL5582695

CN(C)CCNC(=O)Cc1ccc(NC(=O)c2ccc(C(=O)c3ccccc3)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.61
KMT2A Q03164 6/20 0.56
MEN1 O00255 5/20 0.56
RAB9A P51151 2/20 0.56
NPC1 O15118 1/20 0.56
POLB P06746 3/20 0.55
KDM4E B2RXH2 1/20 0.55
HTT P42858 1/20 0.55
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
FFAR1 O14842 1/20 0.52
NR1H4 Q96RI1 1/20 0.50
MCHR1 Q99705 1/20 0.49
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
BCHE P06276 1/20 0.47
ACHE P22303 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5582552 0.96 KMT2A (0.59) TDP1KMT2AMEN1POLBKDM4E
SCHEMBL14454887 0.91 NR1H4 (0.63) TDP1KMT2AMEN1POLBKDM4E
Hydrochloric Acid SCHEMBL5583003 0.90 NR1H4 (0.62) TDP1KMT2AMEN1POLBKDM4E
SCHEMBL5583103 0.85 RAB9A (0.62) TDP1KMT2AMEN1RAB9ANPC1
SCHEMBL5582719 0.82 MEN1 (0.56) KMT2AMEN1RAB9ANPC1NR1H4
SCHEMBL5582690 0.81 MAPK1 (0.55) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL11570271 0.79 KCNH2 (0.69) KMT2AMEN1KDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL11570396 0.78 KCNH2 (0.67) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL5582704 0.78 MCHR1 (0.70) TDP1KMT2AMEN1RAB9ANPC1
SCHEMBL5582571 0.77 TGM2 (0.54) POLBBCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US claimed
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US disclosed
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US disclosed
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US disclosed
US-7115750-B1 Melanin concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-10-03 US disclosed
EP-1218336-A2 MELANIN CONCENTRATING HORMONE ANTAGONIST Takeda Chemical Industries, Ltd. (JP) 2002-07-03 EP disclosed
WO-2001021577-A2 MELANIN CONCENTRATING HORMONE ANTAGONIST TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173498-A1 Melanin concentrating hormone antagonist MC1R, MCHR1, MCHR2 TDP1 4545/4885KMT2A 1886/4885MEN1 380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.